Higher Donor Age and Severe Microvascular Inflammation Are Risk Factors for Chronic Rejection After Treatment of Active Antibody-Mediated Rejection

ABSTRACT:

SUBMITTER: Banno T 

PROVIDER: S-EPMC10869508 | biostudies-literature | 2024 Jan

REPOSITORIES: biostudies-literature